«We provide a framework for incorporating
tumor imaging features and renal function into treatment selection, which may help to inform physicians regarding the appropriateness of surgery in patients with CKD,» Kang said.
«Particularly in such patients with underlying CKD, our modeling results support the integration of renal
tumor anatomic
features at cross-sectional
imaging into decision making for treatment of small renal masses and may be used to provide a patient - centered framework for selection of optimal candidates for ablative therapy,» Kang said.
In a study presented in the
featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT
imaging to show that the amount of cell - free
tumor DNA circulating in the bloodstream correlates with
tumor metabolism (linked to cancer aggressiveness), not
tumor burden (amount of cancer in the body).